Clonidine for Analgesia to Preterm Infants During Neonatal Intensive Care

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions
Intensive Care, NeonatalAnalgesiaHypnotics and Sedatives
Interventions
DRUG

Clonidine

"Clonidine will be administered to preterm infants in need of analgesia and sedation; either as the primary drug for comfort and light sedation or as an add-on drug to opioids according to an algorithm based on pain and sedative scoring results. Opioids are mostly given to postoperative patients. These drugs (morphine or fentanyl) will not be studied, but a baseline PK sample will be taken to correlate to the baseline aEEG."

Trial Locations (2)

221 85

Skane University Hospital, Lund

171 76

Marco Bartocci, Stockholm

All Listed Sponsors
collaborator

Lund University

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

Helsinki University Central Hospital

OTHER

collaborator

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

collaborator

Örebro University, Sweden

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

collaborator

University of Tartu

OTHER

collaborator

University of Colorado, Denver

OTHER

lead

Region Skane

OTHER

NCT04928651 - Clonidine for Analgesia to Preterm Infants During Neonatal Intensive Care | Biotech Hunter | Biotech Hunter